Analysts Anticipate MedEquities Realty Trust Inc (MRT) Will Announce Earnings of $0.31 Per Share

Analysts expect MedEquities Realty Trust Inc (NYSE:MRT) to report earnings per share (EPS) of $0.31 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for MedEquities Realty Trust’s earnings, with the lowest EPS estimate coming in at $0.30 and the highest estimate coming in at $0.32. MedEquities Realty Trust posted earnings of $0.27 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 14.8%. The company is expected to issue its next quarterly earnings results on Monday, February 26th.

According to Zacks, analysts expect that MedEquities Realty Trust will report full year earnings of $1.12 per share for the current year, with EPS estimates ranging from $1.11 to $1.13. For the next fiscal year, analysts anticipate that the company will report earnings of $1.26 per share, with EPS estimates ranging from $1.18 to $1.34. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for MedEquities Realty Trust.

MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings results on Tuesday, November 7th. The financial services provider reported $0.17 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.13). MedEquities Realty Trust had a net margin of 35.61% and a return on equity of 5.88%. The business had revenue of $15.77 million during the quarter, compared to analyst estimates of $15.49 million.

Several equities analysts recently weighed in on the company. B. Riley reaffirmed a “buy” rating on shares of MedEquities Realty Trust in a research note on Wednesday, November 1st. Capital One Financial reaffirmed an “equal weight” rating on shares of MedEquities Realty Trust in a research note on Sunday, October 22nd. KeyCorp reaffirmed a “buy” rating and issued a $13.00 price objective on shares of MedEquities Realty Trust in a research note on Tuesday, September 26th. Zacks Investment Research raised MedEquities Realty Trust from a “sell” rating to a “hold” rating and set a $12.00 price objective for the company in a research note on Wednesday, November 15th. Finally, ValuEngine raised MedEquities Realty Trust from a “hold” rating to a “buy” rating in a research note on Friday, December 1st. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus target price of $13.00.

MedEquities Realty Trust (MRT) traded down $0.17 during midday trading on Friday, reaching $10.84. The company had a trading volume of 360,700 shares, compared to its average volume of 198,222. MedEquities Realty Trust has a 12-month low of $10.06 and a 12-month high of $13.06. The stock has a market cap of $344.23, a P/E ratio of 27.10 and a beta of -0.74.

In related news, Director Randy L. Churchey purchased 5,300 shares of the company’s stock in a transaction on Monday, November 20th. The stock was bought at an average price of $10.87 per share, with a total value of $57,611.00. Following the completion of the transaction, the director now owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John W. Mcroberts purchased 18,000 shares of the company’s stock in a transaction on Friday, November 17th. The shares were bought at an average cost of $10.74 per share, with a total value of $193,320.00. The disclosure for this purchase can be found here. Insiders purchased a total of 23,600 shares of company stock valued at $254,129 over the last ninety days. 2.50% of the stock is currently owned by company insiders.

A number of institutional investors have recently added to or reduced their stakes in MRT. Schwab Charles Investment Management Inc. increased its position in MedEquities Realty Trust by 59.0% during the second quarter. Schwab Charles Investment Management Inc. now owns 509,750 shares of the financial services provider’s stock worth $6,434,000 after buying an additional 189,219 shares in the last quarter. American Century Companies Inc. increased its position in MedEquities Realty Trust by 11.2% during the third quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock worth $20,283,000 after buying an additional 174,261 shares in the last quarter. State Street Corp increased its position in MedEquities Realty Trust by 41.7% during the second quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock worth $6,684,000 after buying an additional 155,934 shares in the last quarter. Prudential Financial Inc. increased its position in MedEquities Realty Trust by 5.4% during the third quarter. Prudential Financial Inc. now owns 2,658,837 shares of the financial services provider’s stock worth $31,242,000 after buying an additional 136,499 shares in the last quarter. Finally, OxFORD Asset Management LLP increased its position in MedEquities Realty Trust by 393.3% during the second quarter. OxFORD Asset Management LLP now owns 111,881 shares of the financial services provider’s stock worth $1,412,000 after buying an additional 89,200 shares in the last quarter. 93.19% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Analysts Anticipate MedEquities Realty Trust Inc (MRT) Will Announce Earnings of $0.31 Per Share” was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://stocknewstimes.com/2018/01/16/analysts-anticipate-medequities-realty-trust-inc-mrt-will-announce-earnings-of-0-31-per-share.html.

About MedEquities Realty Trust

MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply